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Purpose of the study
Ten years have passed since the first cases of lipodystrophy
were described and there are no real incidence data on the
different body physical changes (BPCs) in the HIV popu-
lation under antiretroviral treatment (ART) in Spain. A
specific survey was designed to collect information about
BPCs perceived by patients (pts) and their physicians.
Methods
The survey on BPCs consisted of two parallel question-
naires, for patient and physician. Ethics Committee
approval was received and patient's informed consent was
requested to participate. Estimating a 25% BPCs incidence
(10% relative error) in the HIV+ Spanish population tak-
ing ART (>60,000 pts) and 20% surveys missing, a sample
size of 1,020 pts was calculated for a multistage stratified
sampling as follows: the 17 Autonomous Communities
(ACs) were grouped in 12 strata and 102 physician-sites
were allocated among stratum according to their weights
[stratum sampling fraction 0.017 (0.014–0.026)]. In each
centre, physician was selected by single random sampling,
whereas the 10 patients to be surveyed were selected using
systematic sampling with random start point from
patients visiting the physician in January 2008. Results are
shown as weighted rates based on the population per AC
over the total surveyed sample (95% CI).
Summary of results
Finally, 965 patient-physician surveys were collected in 98
physician-sites: mean patient age was 43.7 ± 8.5 yrs, with
26.4% females and 39% IDU risk behavior. Median time
on ART was 87 months (Q1–Q3, 41–126). 539 patients
(55.1%, 95% CI: 52.0–58.1) answered positively to have
perceived one or more BPCs as 55.2% physician did (95%
CI: 52.1–58.2); there was 83.3% patient-physician overall
agreement. The most frequent BPC perceived was lipoat-
rophy, followed by lipohypertrophy and color changes in
the skin and in the eyes (see Table 1). Although no gender
difference was shown for global BPCs incidence, more
female patients perceived lipoatrophic events than male
patients in arms (p = 0.009) and buttocks (p < 0.007).
Conclusion
A high proportion of patients under ART in Spain refer
changes in their physical appearance. The prevention of
the potential negative impact of BPC on patients' self-
esteem should be considered among the antiretroviral
treatment end-points.
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Table 1: Body physical changes.
Lipoatrophy Lipohypertrophy Skin color change Eyes color change
%subjects (95%CI) %subjects (95%CI) %subjects (95%CI) %subjects (95%CI)
Patients 46.8 (43.7–49.8) 28.7 (25.9–31.4) 5.9 (4.5–7.4) 3.9 (2.7–5.5)
Physicians 49.4 (46.3–53.5) 25.7 (23.0–28.4) 2.4 (1.4–3.3) 3.1 (2.1–4.2)Page 2 of 2
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